Download PDF
Thorac Cardiovasc Surg 2014; 62(07): 561-568
DOI: 10.1055/s-0034-1372349
Original Cardiovascular
Georg Thieme Verlag KG Stuttgart · New York

The Influence of the Metabolic Syndrome on Atrial Fibrillation Occurrence and Outcome after Coronary Bypass Surgery: A 3-Year Follow-up Study

Branislava Ivanovic
1   Department of Cardiology, Clinical Centre of Serbia, Belgrade, Serbia
2   Medical Faculty, University of Belgrade, Belgrade, Serbia
,
Marijana Tadic
3   Department of Cardiology, University Clinical Hospital Centre “Dr Dragisa Misovic,” Belgrade, Serbia
,
Zeljko Bradic
4   Department of Anesthesiology, Clinical Centre of Serbia, Belgrade, Serbia
,
Nevenka Zivkovic
1   Department of Cardiology, Clinical Centre of Serbia, Belgrade, Serbia
,
Dejana Stanisavljevic
2   Medical Faculty, University of Belgrade, Belgrade, Serbia
5   Institute for Medical Statistics and Informatics, Medical Faculty, University of Belgrade, Belgrade, Serbia
,
Vera Celic
2   Medical Faculty, University of Belgrade, Belgrade, Serbia
3   Department of Cardiology, University Clinical Hospital Centre “Dr Dragisa Misovic,” Belgrade, Serbia
› Author Affiliations
Further Information

Publication History

18 December 2013

08 February 2014

Publication Date:
21 April 2014 (online)

    Permissions and Reprints All articles of this category

Abstract

Background We sought to investigate the influence of the metabolic syndrome (MS) on new-onset postoperative atrial fibrillation (POAF), and occurrence of major adverse cardiovascular and cerebrovascular events (MACCE) in a period of 3 years after isolated coronary artery bypass grafting (CABG) surgery.

Methodology The study included 460 patients who underwent the first CABG operation without baseline atrial fibrillation. The MS was defined by the presence of three or more Adult Treatment Panel (ATP)–American Heart Association (AHA)– National Heart, Lung, and Blood (NHLB) Institute criteria. POAF was diagnosed by continuous electrocardiographic monitoring during the first 48 to 72 hours after CABG. All the patients were followed up for at least 3 years after surgery.

Results The MS and its criteria were significantly associated with POAF and MACCE occurrence in the 3-year period after isolated CABG surgery. Among the MS risk factors, hypertension, abdominal obesity, and the increased fasting glucose level were independently associated with both POAF and MACCE onset in the observed patients. Individuals with four or five MS criteria have similar risk of POAF or MACCE as individuals with three MS criteria. In the 3-year period of follow-up, the MS was proven to be associated with MACCE occurrence, independently of hypertension, diabetes, and obesity defined by body mass index.

Conclusions The MS and its criteria significantly increased risk of POAF and MACCE in a 3-year period. The MS, irrespective of hypertension, diabetes, and obesity, was associated with POAF and MACCE in the patients who underwent CABG.

Keywords

atrial fibrillation - metabolic syndrome - coronary artery bypass grafting - hypertension - diabetes
 

  • References

  • 1 Bramer S, van Straten AH, Soliman Hamad MA, Berreklouw E, Martens EJ, Maessen JG. The impact of new-onset postoperative atrial fibrillation on mortality after coronary artery bypass grafting. Ann Thorac Surg 2010; 90 (2) 443-449
    CrossrefPubMedGoogle Scholar
  • 2 Bramer S, van Straten AH, Soliman Hamad MA, Berreklouw E, van den Broek KC, Maessen JG. Body mass index predicts new-onset atrial fibrillation after cardiac surgery. Eur J Cardiothorac Surg 2011; 40 (5) 1185-1190
    PubMedGoogle Scholar
  • 3 Movahed MR, Hashemzadeh M, Jamal MM. Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease. Int J Cardiol 2005; 105 (3) 315-318
    CrossrefPubMedGoogle Scholar
  • 4 Hurt C, Coisne A, Modine T , et al. Contrasting effects of diabetes and metabolic syndrome on post-operative atrial fibrillation and in-hospital outcome after cardiac surgery. Int J Cardiol 2013; 167 (5) 2347-2350
    CrossrefPubMedGoogle Scholar
  • 5 Tadic M, Ivanovic B, Zivkovic N. Predictors of atrial fibrillation following coronary artery bypass surgery. Med Sci Monit 2011; 17 (1) CR48-CR55
    PubMedGoogle Scholar
  • 6 Echahidi N, Mohty D, Pibarot P , et al. Obesity and metabolic syndrome are independent risk factors for atrial fibrillation after coronary artery bypass graft surgery. Circulation 2007; 116 (11, Suppl): I213-I219
    PubMedGoogle Scholar
  • 7 Ozyazicioglu A, Yalcinkaya S, Vural AH, Yumun G, Bozkurt O. Effects of metabolic syndrome on early mortality and morbidity in coronary artery bypass graft patients. J Int Med Res 2010; 38 (1) 202-207
    CrossrefPubMedGoogle Scholar
  • 8 Echahidi N, Pibarot P, Després JP , et al. Metabolic syndrome increases operative mortality in patients undergoing coronary artery bypass grafting surgery. J Am Coll Cardiol 2007; 50 (9) 843-851
    CrossrefPubMedGoogle Scholar
  • 9 Pimenta E, Passarelli Jr O, Borelli F , et al. Metabolic syndrome in patients undergoing coronary artery bypass graft: prevalence and a marker of morbidity/mortality during hospitalization and 30 days after hospital discharge. Arq Bras Cardiol 2007; 88 (4) 413-417
    CrossrefPubMedGoogle Scholar
  • 10 Grundy SM, Cleeman JI, Daniels SR , et al; American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112 (17) 2735-2752
    CrossrefPubMedGoogle Scholar
  • 11 American Diabetes Association. Standards of medical care in diabetes—2009. Diabetes Care 2009; 32 (Suppl. 01) S13-S61
    CrossrefPubMedGoogle Scholar
  • 12 Mancia G, De Backer G, Dominiczak A , et al; ESH-ESC Task Force on the Management of Arterial Hypertension. 2007 ESH-ESC Practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension. J Hypertens 2007; 25 (9) 1751-1762
    CrossrefPubMedGoogle Scholar
  • 13 Mottillo S, Filion KB, Genest J , et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 2010; 56 (14) 1113-1132
    CrossrefPubMedGoogle Scholar
  • 14 Iso H, Sato S, Kitamura A , et al. Metabolic syndrome and the risk of ischemic heart disease and stroke among Japanese men and women. Stroke 2007; 38 (6) 1744-1751
    CrossrefPubMedGoogle Scholar
  • 15 Girerd N, Pibarot P, Fournier D , et al. Middle-aged men with increased waist circumference and elevated C-reactive protein level are at higher risk for postoperative atrial fibrillation following coronary artery bypass grafting surgery. Eur Heart J 2009; 30 (10) 1270-1278
    CrossrefPubMedGoogle Scholar
  • 16 Osranek M, Fatema K, Qaddoura F , et al. Left atrial volume predicts the risk of atrial fibrillation after cardiac surgery: a prospective study. J Am Coll Cardiol 2006; 48 (4) 779-786
    CrossrefPubMedGoogle Scholar
  • 17 Tadic M, Ivanovic B, Cuspidi C. What do we currently know about metabolic syndrome and atrial fibrillation?. Clin Cardiol 2013; 36 (11) 654-662
    CrossrefPubMedGoogle Scholar
  • 18 Watanabe H, Tanabe N, Watanabe T , et al. Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study. Circulation 2008; 117 (10) 1255-1260
    CrossrefPubMedGoogle Scholar
  • 19 Hung CL, Chao TF, Lai YH , et al. The relationship among atrium electromechanical interval, insulin resistance, and metabolic syndrome. Can J Cardiol 2013; 29 (10) 1263-1268
    CrossrefPubMedGoogle Scholar
  • 20 Bell DS, O'Keefe JH. Metabolic syndrome and postoperative atrial fibrillation (POAF). Eur Heart J 2009; 30 (10) 1167-1168
    CrossrefPubMedGoogle Scholar
  • 21 Stevenson IH, Teichtahl H, Cunnington D, Ciavarella S, Gordon I, Kalman JM. Prevalence of sleep disordered breathing in paroxysmal and persistent atrial fibrillation patients with normal left ventricular function. Eur Heart J 2008; 29 (13) 1662-1669
    CrossrefPubMedGoogle Scholar
  • 22 Dimmer C, Tavernier R, Gjorgov N, Van Nooten G, Clement DL, Jordaens L. Variations of autonomic tone preceding onset of atrial fibrillation after coronary artery bypass grafting. Am J Cardiol 1998; 82 (1) 22-25
    PubMedGoogle Scholar
  • 23 Ehrlich JR, Hohnloser SH, Nattel S. Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence. Eur Heart J 2006; 27 (5) 512-518
    CrossrefPubMedGoogle Scholar
  • 24 Voigt N, Heijman J, Wang Q , et al. Cellular and molecular mechanisms of atrial arrhythmogenesis in patients with paroxysmal atrial fibrillation. Circulation 2014; 129 (2) 145-156
    CrossrefPubMedGoogle Scholar
  • 25 Ramlawi B, Otu H, Mieno S , et al. Oxidative stress and atrial fibrillation after cardiac surgery: a case-control study. Ann Thorac Surg 2007; 84 (4) 1166-1172 , discussion 1172–1173
    CrossrefPubMedGoogle Scholar
  • 26 Fukui A, Takahashi N, Nakada C , et al. Role of leptin signaling in the pathogenesis of angiotensin II-mediated atrial fibrosis and fibrillation. Circ Arrhythm Electrophysiol 2013; 6 (2) 402-409
    CrossrefPubMedGoogle Scholar
  • 27 Kourliouros A, Karastergiou K, Nowell J , et al. Protective effect of epicardial adiponectin on atrial fibrillation following cardiac surgery. Eur J Cardiothorac Surg 2011; 39 (2) 228-232
    CrossrefPubMedGoogle Scholar
  • 28 Deng Y, Scherer PE. Adipokines as novel biomarkers and regulators of the metabolic syndrome. Ann N Y Acad Sci 2010; 1212: E1-E19
    PubMedGoogle Scholar
  • 29 Rodrigo R, Korantzopoulos P, Cereceda M , et al. A randomized controlled trial to prevent post-operative atrial fibrillation by antioxidant reinforcement. J Am Coll Cardiol 2013; 62 (16) 1457-1465
    CrossrefPubMedGoogle Scholar
  • 30 Harling L, Rasoli S, Vecht JA, Ashrafian H, Kourliouros A, Athanasiou T. Do antioxidant vitamins have an anti-arrhythmic effect following cardiac surgery? A meta-analysis of randomised controlled trials. Heart 2011; 97 (20) 1636-1642
    CrossrefPubMedGoogle Scholar
  • 31 Gu WJ, Wu ZJ, Wang PF, Aung LH, Yin RX. N-Acetylcysteine supplementation for the prevention of atrial fibrillation after cardiac surgery: a meta-analysis of eight randomized controlled trials. BMC Cardiovasc Disord 2012; 12: 10
    CrossrefPubMedGoogle Scholar
  • 32 Mariscalco G, Engström KG. Postoperative atrial fibrillation is associated with late mortality after coronary surgery, but not after valvular surgery. Ann Thorac Surg 2009; 88 (6) 1871-1876
    CrossrefPubMedGoogle Scholar